• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Drugs to be Discontinued

Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable. These drugs include those that are life-supporting, life-sustaining or for use in the prevention or treatment of a debilitating disease or condition, including any such drug used in emergency medical care or during surgery). The discontinuations provided below reflect information received from manufacturers, and are for informational purposes only.

For additional, complete information on discontinued drugs, please consult the following:
Drugs@FDA
Orange Book Query
Orange Book Monthly Additions and Deletions
 

Drug NameCompany InformationNote
Ambenonium Chloride (Mytelase)
 
6/25/2012
Sanofi-Aventis
1-800-981-2491
 
Mytelase (ambenonium chloride) Tablets, indicated for the treatment of patients with myasthenia gravis, has been discontinued. The product discontinuation is not related to product safety or any FDA action. Sanofi communicated this decision to FDA on October 6, 2010.  The last manufactured LOT of Mytelase will expire on March 31, 2013
 

Aminophylline Tablets USP, 100 mg and 200 mg

 

4/4/2012

West-Ward Pharmaceutical Corp.

1-800-631-2174
 

West-Ward has made a business decision to discontinue Aminophylline Tablets.

Asacol (mesalamine) Delayed-Release Tablets 400 mg

 

5/7/2013

Warner Chilcott
1-800-521-8813 Ext. 3236
 
Warner Chilcott has discontinued this product.
Asenapine (Saphris) unflavored tablets
 
8/5/2013

Merck Sharp & Dohme Corp. a subsidiary of Merck and Co., Inc.

Merck National Service Center Telephone Number:
1-800-672-6372
 

All strengths of the unflavored tablets will be permanently discontinued.

The Saphris black cherry flavor Tablets will remain available.
 

Asparaginase Injection (Elspar)
10,000 IU/vial (NDC 67386-411-51)
 
08/03/2012
Lundbeck LLC Customer Service Number:
1-888-514-5204
Lundbeck will be discontinuing Elspar in December 2012 See Dear Healthcare Provider Letter (PDF -335KB) from Lundbeck (updated 08/03/2012)  

Atropine 1% 2mL steri-units unpreserved

 

12/18/2012
 

Alcon
1-800-862-5266
Due to low demand Alcon has decided to discontinue this product.

Bethanechol Chloride
5, 10, 15,  25, 50 mg Tablets


NDC 0115-9511-01
NDC 0115-9511-02
NDC 0115-9522-01
NDC 0115-9522-02
NDC 0115-9533-01
NDC 0115-9533-02
NDC 0115-9544-01
NDC 0115-9544-02

 

6/14/2013

Impax Laboratories
Global Pharmaceuticals Distribution
Customer Service:
1-800-934-6729

 

Impax has made a business decision to discontinue this product.  Last projected sale date anticipated in December, 2013.
HELIDAC (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (NDC 65483-495-14)
 
Prometheus Laboratories Inc.
1-888-423-5227 option 3  
Shortage of an active ingredient. Prometheus has discontinued this product.
Bupivacaine Hydrochloride Injection; NDC 0409-1164-01
 
11/7/2013 
Hospira, Inc.
1-877-946-7747
Hospira has made a business decision to discontinue 0.75% Bupivacaine Hydrochloride Injection USP, 7.5 mg/mL, 30 mL Single Dose Ampul
Calcitriol 1 mcg/mL Injection

5/18/2012
West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
West-Ward no longer distributes Calcitriol 1 mcg/mL Injection.
 
Calcitriol Injection (1mcg/mL); 1mL
 
1/31/2014 
Fresenius Kabi, USA
1-888-386-1300 
Fresenius-Kabi is discontinuing this product (NDC #63323-731-01).  Product with 3 month dating (expiry 4/30/2014) is currently available by request for direct orders.
 

Cefuroxime Sodium Injection, 1.5 g Fliptop Vial; NDC 0409-0802-01

Cefuroxime Sodium Injection, 7.5 g Pharmacy Bulk package Fliptop Vial; NDC 0409-0803-01

 

2/20/2013

Hospira, Inc.
1-877-946-7747
 
Due to unavailability of the Active Pharmaceutical Ingredient, Hospira has made a business decision to discontinue manufacturing.
 
Chloral Hydrate Oral Solution

5/25/2012

Pharmaceutical Associates, Inc
Customer Service: 

1-864-277-7282

PAI has discontinued manufacturing of Chloral Hydrate Oral Solution 16 fl oz retail package (NDC 00121-0532-16) and 5ml Unit Dose (NDC 00121-0532-05).  

This is solely a business decision from PAI and is not related to any FDA actions.

Chloral Hydrate (Somnote) soft gel capsule

 

1/4/2013
 

Breckenridge Pharmaceutical

Customer Service:
1-800-367-3395

Breckenridge Pharmaceutical, Inc. has discontinued Somnote due to manufacturing and supply issues.
 

Chloroquine 250 mg (2790-06-0115) and 500 mg (7010-09-0115) tablets

 

5/6/2013

Impax Laboratories
Customer Service: 1-800-934-6729
 
Supplies anticipated to be exhausted in approximately October 2013 for the 250 mg and July 2013 for the 500 mg.

Chlorothiazide Tablets USP, 250mg
NDC 0143-1209-01


5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174

Bottles of 100's

West-Ward has made a business decision to discontinue this product.

Cyanide Antidote Kit

5/22/2012
Akorn Pharmaceuticals
1-800-932-5676
 
Akorn is discontinuing the manufacture of this product and the components for use in this product.

Daclizumab (Zenapax) sterile Concentrate for Injection


12/18/2009

Hoffman-La RochePlease see Dear Healthcare Professional Letter (PDF - 55KB) for additional information
 

Demeclocycline 150 mg (NDC: 2111-01-0115) and 300 mg (NDC: 2122-14-0115) tablets

 

5/6/2013

Impax Laboratories
1-800-934-6729
 
Supplies anticipated to be exhausted in approximately October 2013.

Denileukin diftitox (Ontak) Injection, 150 mcg/mL

 

1/31/2014

Eisai, Inc.
1-888-422-4743
 
Eisai, Inc. has made the decision to discontinue this product.

Denileukin diftitox (Ontak) Injection, 150 mcg/ mL (NDC: 62856-0603-01)


1/31/2014 

Eisai, Inc.
1-888-422-4743 
Eisai, Inc. has made the decision to discontinue this product.

Dicyclomine Hydrochloride Capsules, USP 10mg

NDC 0143-3126-01
NDC 0143-3126-10

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's and 1000's
Product Has Been Discontinued
Effective February 8, 2013

Digoxin Injection
0.25 mg/mL, 2 mL


5/15/2012

Sandoz Customer Service:
1-609-627-8500
 Sandoz discontinued manufacturing in March 2011. Sandox is no longer distributing with no plans for re-introduction.

Doxycycline Hyclate

100 mg Tablets

 

1/31/2012

Teva Pharmaceuticals

1-888-838-2872

Teva has made the decision to discontinue this product.

Erythromycin Ethylsuccinate and Acetyl Sulfisoxazole Suspension

11/13/2012
 

Teva Pharmaceuticals
1-888-838-2872
Teva is no longer able to source one of the active ingredients for this product (acetyl sulfisoxazole)

Ethambutol Tablets 100mg (manufactured for VersaPharm)
 

 

NDC 61748-011-01
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174

Bottles of 100's

West-Ward has made a business decision to discontinue this product.

Ethambutol Tablets 400mg (manufactured for VersaPharm)
 

 

NDC 61748-014-06
NDC 61748-014-09
NDC 61748-014-01
NDC 61748-014-10
NDC 61748-014-11
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 60's, 90's, 100's, 1000's and Unit Dose Blister Pack
West-Ward has made a business decision to discontinue this product.

Flavoxate HCl 100mg Tablets

 

NDC 0115-1811-01
NDC 0115-1811-02
 

 

6/14/2013

Impax Laboratories
Global Pharmaceuticals Distribution
Customer Service:
1-800-934-6729
 
Impax has made a business decision to discontinue this product.  Last projected sale date anticipated in December, 2013.
 

Flurazepam Hydrochloride Capsules, USP C-IV 30mg

NDC 0143-3370-01
NDC 0143-3370-05

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's and 500's
Product Has Been Discontinued
Effective February 8, 2013

Fluress Opthalmic Solution
NDC 17478-640-10


1/14/2013

Akorn Pharmaceuticals
1-800-932-5676
The discontinuation of this product from the Akorn product line is not associated with any quality related concern impacting distributed product, and is not expected contribute to any potential drug shortages. Fluress was last manufactured during 1Q 2013.

Fluticasone propionate inhalation powder (Flovent Rotadisk)
 

 

8/31/2004

GlaxoSmithKline
1-888-825-5249
 

Please see Dear Healthcare Professional Letter (PDF - 28KB) for additional information. 

Foscarnet Sodium Injection
 

24 mg/mL; 250 mL bottle
(NDC 0409-3863-02)
 

24 mg/mL; 500 mL bottle
(NDC 0409-3863-05)
 
1/29/2013

 

Hospira, Inc.
Customer Service
1-877-946-7747 
Hospira has discontinued Foscarnet Sodium and now sells and distributes Clinigen’s Foscavir (forscarnet sodium) Injection. 

Fulvestrant (Faslodex*) Injection, 2.5 ml (2 x 2.5 ml pre-filled syringe), (125 mg /2.5 ml (50 mg/ml) FASLODEX intramuscular injection), NDC 0310-0720-2510.

Fulvestrant (Faslodex) Injection: one 5.0 ml syringe (250mg/5ml), NDC 0310-0720-50

 

updated
1/14/2011
 

AstraZeneca Pharmaceuticals LP (AstraZeneca)

Contact the Corporate Communication Center at 1-800-236-9933
 

There is no remaining inventory within AstraZeneca's distribution network. The final expiration date of any Faslodex* (fulvestrant) Injection that may still be remaining in the market place is December 31, 2010.

AstraZeneca is discontinuing supply of the single dose pack. Inventory depletion is expected the week of Jan 17, 2010. The dual dose pack (NDC 0310-0720-10), two 5.0ml syringes (250mg/5ml) continues to be available.

Galantamine HR Extended Release
8, 16, 24 mg Capsules
 
NDC 0115-1120-08
NDC 0115-1120-10
NDC 0115-1120-03
NDC 0115-1121-08
NDC 0115-1121-10
NDC 0115-1121-03
NDC 0115-1122-08
NDC 0115-1122-10
NDC 0115-1122-03
 

 

6/14/2013

Impax Laboratories
Global Pharmaceuticals Distribution
Customer Service:
1-800-934-6729

Impax has made a business decision to discontinue this product.  Last projected sale date anticipated in December, 2013.

Gallium Nitrate (Ganite) Injection

 

4/4/2012

Genta Incorporated
1-888-TO-GENTA)
 
Genta Incorporated has discontinued this product.
 

Glycopyrrolate Tablets USP, 1mg and 2 mg
 

 

NDC 0143-1250-01
NDC 0143-1251-01
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 100's
West-Ward has made a business decision to discontinue these products.
Heparin Sodium in 5% Dextrose premix product

3/18/2011
 
Baxter Customer Service:
(1-888-229-0001)

Heparin Sodium and 0.9% Sodium Chloride Injection product remains available.
 

Dear Valued Baxter Customer Letter (PDF - 29KB)

Hydrochlorothiazide Tablets, USP 50mg
 

 

NDC 0143-1257-01
NDC 0143-1257-10
NDC 0143-1257-51
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 100's, 1000's and 5000's
West-Ward has made a business decision to discontinue this product.

Hydroxychloroquine Sulfate Tablets, USP 200mg

NDC 0143-2128-01

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's
Product Has Been Discontinued
Effective February 8, 2013

INSULIN INJECTION, USP, PURIFIED PORK (Regular Iletin II)
 

 

7/6/2005
 

Eli Lilly and Company
 

 

Interferon Alfacon-1 (Infergen) Injection
 

2/4/2014
 

Kadmon Pharmaceuticals, LLC
1-800-405-8506
 
customerservice@kadmon.com 
Kadmon Pharmaceuticals, LLC has discontinued Infergen 9 mcg and 15 mcg (NDC: 66435-202-09 (6 pack); NDC: 66435-202-95 (single vial); NDC: 66435-201-15 (6 pack); and NDC: 66435-201-96) (single vial).
 
Kadmon has made a business decision to discontinue Infergen as of September 27, 2013.  This decision is not related to any safety issues or FDA actions. 

Isopto Carbachol 1.5% and 3% 15mL

 

12/18/2012

Alcon
1-800-862-5266

Due to low demand Alcon has decided to discontinue this product.
 

Isopto Homatropine 2% and 5% 5mL


12/18/2012

Alcon
1-800-862-5266
Due to low demand Alcon has decided to discontinue this product.
 

Isopto Hyoscine 0.25% 5mL


12/18/2012

Alcon
1-800-862-5266
Due to low demand Alcon has decided to discontinue this product.
 

Isosorbide Dinitrate Sublingual Tablets USP, 2.5 mg and 5 mg

 

5/14/2013

West-Ward Pharmaceutical Corp.
Customer Service:
1-800-631-2174
 
West-Ward has made a business decision to discontinue Isosorbide Dinitrate Sublingual Tablets.

Isradipine (DYNACIRC CR) Tablet, 5 mg and 10 mg
 

 

7/5/2013
 

GlaxoSmithKline

Customer Service
1-800-877-1158

 

GlaxoSmithKline has discontinued marking of DYNACIRC CR Tablets

Lepirudin (rDNA) (Refludan) for Injection

 

5/17/2012
 

Bayer Healthcare Corporation
Customer Service:
1-888-229-0001
 

Bayer Healthcare Corporation has made a decision to discontinue Refludan (lepirudin (rDNA)) for Injection. No further product will be distributed from Bayer after May 31, 2012.
Levobunolol Hydrochloride 0.25% Solution
 
3/14/2014
Pacific Pharma, Inc.
1-800-811-4184  
Pacific Pharma has made a business decision to discontinue this product.
 
Levofloxacin (Levaquin) Injection
 
2/21/2014
 Janssen Pharmaceuticals
1 800 JANSSEN
(1-800-5267736)
 
Janssen Pharmaceuticals have made a business decision to permanently discontinue LEVAQUIN (levofloxacin) Injection (5 mg/mL in 5% Dextrose) Premix in Single-Use Flexible Containers.

Lisinopril and Hydrochlorothiazide (Prinzide) Tablets

10-12.5 mg (NDC 0006-0145-58)

20-12.5 mg (NDC 0006-0140-58)

 

2/19/2013

Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc.

Merck National Service Center Telephone Number:

1-800-672-6372

Permanently discontinued.

Lithium Carbonate Capsules USP, 150mg

NDC 0143-3188-01

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's
Product Has Been Discontinued
Effective February 8, 2013

Lithium Carbonate Capsules USP, 300mg

NDC 0143-1300-01
NDC 0143-1300-10

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's and 1000's
Product Has Been Discontinued
Effective February 8, 2013

Lithium Carbonate Capsules USP, 300mg

NDC 0143-3189-01
NDC 0143-3189-10

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's and 1000's
Product Has Been Discontinued
Effective February 8, 2013
Mebendazole Tablets

10/26/2011

Teva Pharmaceuticals

1-800-545-8800

Dear Valued Customer Letter (PDF - 43KB) 

Mefenemic Acid Capsules, 250mg (Generic Product) (manufactured for Shionogi)
 

 

NDC 66993-070-30
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 30's
West-Ward has made a business decision to discontinue this product.

Mefloquine Hydrochloride Tablets 250 mg
 

 

NDC 0143-1282-22

 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 25's
West-Ward has made a business decision to discontinue this product.

Memantine Hydrochloride (Namenda) 5 mg and 10 mg Tablets

 

2/14/2014

Forest Laboratories, Inc.
Customer Service Department:
1-844-TREAT-AD (1-844-873-2823)

The sale of Memantine Hydrochloride (Namenda)5 mg and 10 mg Tablets, NDA 21-487 indicated for the treatment of moderate to severe dementia of the Alzheimer's type will be
discontinued effective August 15, 2014. The product discontinuation is not related to product safety or efficacy.

Please see the Dear Health Care Provider Letter (PDF - 52KB).
 

Mephobarbital (Mebaral)
32mg tablets, 50mg tablets and 100mg tablets

1/6/2012
 

Lundbeck Inc. Customer service number:
1-888-514-5204

Lundbeck is no longer able to manufacture Mebaral CIV (brand of mephobarbital tablets, USP), and the company's remaining inventory will expire in March 2012. Due to product expiration, we will not be able to make any product shipments after February 29, 2012. Once this current stock of Mebaral is depleted, the product will no longer be available.

Lundbeck is aware of the difficult situation that some patients may face with regard to the upcoming Mebaral discontinuation. The company thoroughly evaluated all avenues for keeping Mebaral available to patients, but ultimately concluded that no matter what steps we took, patients would be forced to transition to a new therapy. Due to the limited remaining Mebaral supply, we encourage patients to work with their physician to transition to alternative therapies rather than starting a new course of therapy with Mebaral. For more information or with questions, Lundbeck’s medical information team can be reached at 866-402-8520.

Methylergonovine maleate (Methergine) Injection and Tablets

 

4/12/2012

Novartis Pharmaceuticals Corporation

1-888-NOW-NOVA

 
 Novartis Pharmaceuticals Corporation has made a decision to discontinue Methergine (methylergonovine maleate) tablets and injection.

Methylprednisolone sodium succinate injection
 

 

1/29/2012

Hospira, Inc.
877-946-7747
Hospira has made a business decision to discontinue Methylprednisolone sodium succinate injection, 40 mg single dose vial (NDC 00409-3217-05), 125 mg single dose vial (NDC 00409-3218-05), 40 mg single dose Univial (NDC 00409-5684-23), 125 mg single dose Univial (NDC 00409-5685-23).)

Minocycline ER 45, 90, 135 mg Tablets

 

NDC 0115-1245-08
NDC 0115-1245-10
NDC 0115-1245-01
NDC 0115-1245-02
NDC 0115-1245-03
NDC 0115-1246-08
NDC 0115-1246-10
NDC 0115-1246-01
NDC 0115-1246-02
NDC 0115-1246-03
NDC 0115-1247-08
NDC 0115-1247-10
NDC 0115-1247-01
NDC 0115-1247-02
NDC 0115-1247-03
 

 

6/14/2013

Impax Laboratories
Global Pharmaceuticals Distribution
Customer Service:
1-800-934-6729

Impax has made a business decision to discontinue this product.  Last projected sale date anticipated in December, 2013.

Naproxen Sodium Tablets USP, 550mg

NDC 0143-9908-01
NDC 0143-9908-05

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's and 500's
Product Has Been Discontinued
Effective February 8, 2013

Neostigmine bromide (Prostigmin) 15 mg Tablets
 
3/12/2014 

Valeant Pharmaceutical North America
1-800-321-4576

Valeant  Pharmaceutical North America (VPNA)   decided to stop distributing and manufacturing Prostigmin Tablets, 15 mg ( neostigmine bromide), supplied as scored, white tablets containing 15 mg neostigmine bromide — bottles of 100 (NDC 0187-3100-10). The last lot manufactured has an expiry date of April 2015. Currently, wholesaler stocks are completely depleted. This product was not marketed under an approved NDA. VPNA will not submit a NDA to pursue commercialization.  It is a business decision to discontinue distribution.
 

Nimodipine Capsules 30mg
 

 

4/26/2013

Teva Pharmaceuticals
1-888-838-2872
Teva has made the decision to discontinue these products.
Norfloxacin (Noroxin) Tablets
 
4/8/2014
Merck Sharp & Dohme Corp. a subsidiary of Merck and Co., Inc.
1-800-672-6372
 
Permanently Discontinued.  For additional information please contact:  Merck National Service Center Telephone Number: 1-800-672-6372  

Ondansetron Injection 32 mg/50 mL premixed bags
(NDC 25021-0776-50)
 

Sagent Pharmaceuticals
1-866-625-1618
 
Sagent has discontinued their ondansetron premixed bags.
Ondansetron Injection 32 mg/50 mL premixed bags
(NDC 00703-7239-39)
Teva Pharmaceuticals
1-800-545-8800
Teva has voluntarily withdrawn their application for this product and has discontinued the manufacturing.
 
Ondansetron Injection 32 mg/50 mL premixed bags

5/18/2012
West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
West-Ward no longer distributes Ondansetron premixed bags.
 
Ondansetron Injection 32 mg/50 mL premixed bags
 
4/16/2013

Sagent Pharmaceuticals
1-866-625-1618

Teva Pharmaceuticals
1-800-545-8800

Hospira, Inc.
Customer Service:
1-877-946-7747

Baxter
Customer Service:
1-888-229-0001
 

Discontinuation of the manufacture of the drug.

Product discontinued due to FDA new drug safety communication issued.

Pancrelipase (Pancrease) capsules

 

5/17/2006

McNeil Consumer and Specialty Pharmaceuticals
888-440-7903

Other pancrelipase products continue to be available

Dear Health Care Provider Letter

 

Phenobarbital Oral Solution

 

4/5/2012

Pharmaceutical Associates, Inc
Customer Service: 

1-864-277-7282

PAI has discontinued manufacturing of Phenobarbital Oral Solution (20mg/5mL) 5 mL unit dose package (NDC-00121-0531-05).

Phenylephrine (MYDFRIN) Ophthalmic Solution

 

4/01/2014

Alcon
(1-800-451-3937)
 
Sandoz
(1-800-525-8747)

Alcon has made a business decision to discontinue this product as of April 1, 2014.  

NDC 61314-0342-01  PHENYLEPHRINE HCL 2.5% 3ML
NDC 61314-0342-02  PHENYLEPHRINE HCL 2.5% 5ML

Phenylephrine Ophthalmic Solution

3/18/2014 

Akorn
1-800-932-5676
 Akorn has made a business decision to discontinue this product.  Product manufacture will end by April 30, 2014 and product distribution will end by June 30, 2014.
NDC 17478-0200-20 2.5% 2ml
NDC 17478-0200-12 2.5% 15ml
NDC 17478-0205-10 10% 5ml

Phenytoin Sodium Injection, USP

50 mg/mL; 2 mL Carpuject syringe

NDC 0409-1844-02

 

8/29/2013
 

Hospira, Inc.

1-877-946-7747

Hospira has made the business decision to discontinue Phenytoin Sodium Injection, USP, 50 mg/mL; 2 mL Carpuject syringe.

Ponstel Capsules, USP (Brand Product) (manufactured for Shionogi)
 

 

NDC 59630-400-30
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 30's
West-Ward has made a business decision to discontinue this product.

Potassium Citrate and Citric Acid Oral Solution

 

4/5/2012

Pharmaceutical Associates, Inc
Customer Service: 

1-864-277-7282

PAI has discontinued manufacturing of Potassium Citrate and Citric Acid Oral Solution: Potassium Citrate Monohydrate 1100 mg/5 ml; Citric Acid Monohydrate 334 mg/5 ml (NDC 00121-0676-16).
Potassium citrate/sodium citrate/citric acid monohydrate (Tricitrates) Oral Solution
 
4/5/2012
 
Pharmaceutical Associates, Inc
Customer Service:
1-864-277-7282
PAI has discontinued manufacturing of Tricitrates Oral Solution: Potassium Citrate Monohydrate 550 mg/5 mL; Sodium Citrate Dihydrate 500 mg/5 mL; Citric Acid Monohydrate 334 mg /5 mL  (NDC 00121-0779-16).
 
Potassium citrate/sodium citrate/citric acid monohydrate (Tricitrates SF) Oral Solution
 
4/5/2012
Pharmaceutical Associates, Inc
Customer Service:
1-864-277-7282
PAI has discontinued manufacturing of Tricitrates SF Oral Solution: Potassium Citrate Monohydrate 550 mg/5 mL; Sodium Citrate Dihydrate 500 mg/5 mL; Citric Acid Monohydrate 334 mg /5 mL  (NDC 00121-0677-16).
 

PREZISTA (darunavir) tablet 400MG

NDC is: 59676-561-01

Janssen Therapeutics, Division of Janssen Products, LP
1-800-JANSSEN (1-800-526-7736)
 

Janssen plans to discontinue the PREZISTA 400mg tablet, which will be replaced by the 800mg tablet. Patients who were taking two 400mg tablets will now take one 800mg tablet.
 

Primidone Tablets USP, 50mg
 

 

NDC 0143-1482-01

 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 100's
West-Ward has made a business decision to discontinue this product.

Primidone 50, 250mg Tablets
NDC 0115-1030-01
NDC 0115-1030-02
NDC 0115-1031-01
NDC 0115-1031-03
 

 

6/14/2013
 

Impax Laboratories
Global Pharmaceuticals Distribution
Customer Service:
1-800-934-6729
Impax has made a business decision to discontinue this product.  Last projected sale date anticipated in December, 2013.

Rifampin/Isoniazid

300 mg/150 mg Capsules

NDC 0143-3238-60

NDC 0143-3238-01

NDC 0143-3238-05

 

1/31/2012

West-Ward Pharmaceutical Corporation/Versapharm

1-800-631-2174

Management decision to discontinue manufacture of product.

Final batch of product will be released March 2013.

Rivastigmine tartrate (Exelon) oral solution 2 mg/mL; 120 mL

 

1/29/2014

Novartis Pharmaceuticals Corp.
1-888-669-6682
 
Novartis has made a business decision to discontinue Rivastigmine tartrate (Exelon) oral solution.

Sitagliptin and Simvastatin (Juvisync)

 

9/26/2013

Merck Sharp & Dohme Corp. a subsidiary of Merck and Co.,Inc.
1-800-672-6372
Permanently discontinued for business reasons. Sitagliptin and Simvastatin will continue to be available as separate drugs.
Sodium Chloride 23.4%; NDC 0409-1130-02
 
11/19/2013  
Hospira, Inc.
1-877-946-7747
Hospira has made a business decision to discontinue 4 mEq/mL; 250 mL bottle.

Terbutaline 2.5 mg (NDC: 2611-01-0115) and 5 mg (NDC: 2622-01-0115) tablets

 

5/6/2013

Impax Laboratories

1-800-934-6729

Supplies anticipated to be exhausted in approximately October 2013.

Tetracaine HCL (Pontocaine) Injection (all products)

 

12/9/2010

Hospira, Inc.
1-877-946-7747
Hospira has made a business decision to discontinue these products. http://hospiraadvancewithus.com/ disclaimer icon

Thiopental (Pentothal) Injection

 

1/25/2011

Hospira, Inc.
1-877-946-7747
Hospira has made the decision to discontinue this product.
Tositumomab and Iodine I 131 Tositumomab (Bexxar)
 
2/18/2014
GlaxoSmithKline
1-888-825-5249 
BEXXAR (Tositumomab and Iodine I 131 Tositumomab) is being discontinued.  The product discontinuation is not related to product safety or any FDA action.   BEXXAR will no longer be available effective February 20, 2014. 
Triamcinolone Hexacetonide (Aristospan) injection 5 mL fill in a 10 mL vial (NDC 0781-3084-75)
 
4/9/2013
Sandoz Customer Service:
1-609-627-8500 
 
Sandoz has made the decision to permanently discontinue this product.

Trihexyphenidyl Hydrochloride Tablets, USP 2mg
 

 

NDC 0143-1764-01
NDC 0143-1764-10
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 100's and 1000's
West-Ward has made a business decision to discontinue this product.

Trihexyphenidyl Hydrochloride Tablets USP 5mg
 

 

NDC 0143-1763-01
NDC 0143-1763-10
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 100's and 1000's
West-Ward has made a business decision to discontinue this product.

Trihexyphenidyl Hydrochloride Tablets, USP 2mg

NDC 0143-1764-01
NDC 0143-1764-10

2/8/2013

West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
Bottles of 100's and 1000's
Product Has Been Discontinued
Effective February 8, 2013

Verapamil HCL (Covera HS) (180 mg or 240 mg) extended-release tablets

 

6/15/2012
 

Pfizer Customer Service:
1-800-438-1985
 
Discontinued due to business reasons.

Zebutal Capsules (Butalbital, Acetaminophen, Caffeine), 50/500/40mg (manufactured for Shionogi)
 

 

NDC 59630-170-11
 

5/23/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Bottles of 100's
West-Ward has made a business decision to discontinue this product.